Drug intelligence / Profile preview

rehmannia glutinosa leaf extract

Development stage
Unknown
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Rehmannia glutinosa leaf extract (RGLE) is a botanical extract derived from the leaves of Rehmannia glutinosa, a species widely used in traditional Chinese medicine. While the root is more commonly employed, recent research on the **leaf extract** has demonstrated a range of potential pharmacological effects, including anti-inflammatory, antioxidant, and immunomodulatory actions. RGLE has recently been studied as an oral supplement for conditions such as moderate to severe acne vulgaris, where it showed a clinically significant reduction in acne severity, as well as improvements in skin hydration and quality of life, without reported safety concerns. RGLE is also believed to contain active metabolites such as verbascoside, catalpol, and various glycosides and phenylethanol glycosides that may underlie its pharmacological activities. These compounds are proposed to act on molecular targets and pathways involved in inflammation, immune modulation, and skin barrier function. The exact mechanism of action in humans remains an area of ongoing research. RGLE is available commercially under brand names such as Verbasnol and is typically administered orally as a dietary supplement[9][7][5].

Brand names
Verbasnol
Other names
RGLERehmannia glutinosa leaf-based extract
02

Targets

TYR (Tyrosinase)MMP12 (Macrophage Metalloelastase)

Beyond the preview

Go deeper on rehmannia glutinosa leaf extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on rehmannia glutinosa leaf extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call